LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Policy Proposal for New Genomic Techniques – Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides

16/11/2022
POSITION LETTER

Brussels, 14 November 2022


Re: Policy Proposal for New Genomic Techniques


Dear Vice-President,

Dear Commissioner,


The undersigned value chain partners welcome the Commission’s plans for an Initiative on New Genomic Techniques (NGTs) and support the proposal for an enabling regulatory framework. We fully concur with the conclusions of the Public Consultation where almost 80% of the participants responded that the existing provisions of the current GMO legislation are not adequate for plants obtained by targeted mutagenesis or cisgenesis. This is a clear request of relevant stakeholders for a new framework for plants obtained by NGTs.


Considering the increasing global challenges in view of the productivity of sustainable agriculture, climate change and food security, we deem that the EU should not further delay its initiative and fall even more behind on the issue. There is a growing number of countries that globally implement enabling policy approaches for NGTs, and European agriculture and some other of the EU’s most innovative sectors are at risk of being deprived of scientific progress, putting them at a competitive disadvantage compared to their counterparts. Consequently, Europe’s leading position in innovative breeding is at stake, as are EU sustainability goals, jobs in agriculture, bioindustries and their associated value chains, and international trade flows. This does not only concern plant production but is also valid for the livestock sector and the fermentation industry.


We welcome the Commission’s conclusion from the NGT Study in 2021 that a differentiated regulatory approach is needed. Indeed, NGTs are versatile and can be applied in different ways. The resulting products can be like GMOs or indistinguishable from conventional plant varieties.

We nevertheless have the impression that the scenarios as presented by the Commission during the targeted stakeholder consultation, as well as the recent EFSA statement on the criteria for risk assessment1, neglect this differentiated approach and consider a mandatory risk assessment step as necessary for all plants obtained by targeted mutagenesis, cisgenesis and intragenesis. The signatories of this letter consider any such approach as disproportionate and unworkable, specifically for SMEs and highlight that under such conditions, NGTs will not deliver on the goals of the Farm to Fork and Biodiversity strategies.

The Commission proposal should reflect these similarities with existing product categories (conventional/ GMOs) in their regulatory proposal to avoid regulatory discrimination of similar products. This is specifically important also in view of the global perspective, considering the trade related challenges that might arise in case the EU proposal would not align with the growing number of policies in other countries. It would have strong implications for the competitiveness of the EU Agri-Food value chain as well as the enforceability of regulations.

Plant breeding has a track record of providing safe and sustainable options to the agri-food value chains. Nevertheless, a sustainability assessment of individual plant characteristics resulting from NGTs risks being reductionistic, hence failing to capture the complexity of sustainability in all its dimensions (socio-economic, environmental) and with that potentially being misleading to customers and consumers. Any sustainability assessment of new plant varieties should be context-dependent, science-based and non-discriminatory in view of the breeding tools that have been used. We regret that there isn’t yet an agreed, harmonised, international approach to sustainability. This makes it difficult to achieve a common understanding about what could represent a sustainable plant characteristic which also depends on the agricultural context and environment e.g., in third export countries, where the crops are grown.

The undersigned agri-food value chain partners are committed to contributing to societal and consumer expectations in terms of healthy diets, biodiversity and a sustainable agricultural model. The NGT study confirmed that “several of the plant products obtained from NGTs” can contribute to various goals of the European Green Deal by saving land resources, allowing a more sustainable use of crop protection products and antibiotics, improving food/feed quality and reducing emissions while stabilizing and increasing crop yields, improving animal health and welfare and ensuring food security.
Given that discussions on the status of NGTs have been going on for more than 14 years, we call on the Commission to ensure that an ambitious policy proposal is presented in a timely manner to enable access to those innovations to EU farmers and the food chain as well as to consumers as soon as possible.
While we strongly welcome the prospect of further policy action in plants, we also would like to encourage the Commission to promptly initiate discussions with the relevant stakeholders, notably the livestock and fermentation sectors, on the review of the regulatory approach in other sectors, in the EU and on a global level.


Yours faithfully,

Céline Duroc, Director General of MAIZ'EUROP' for the Platform Agriculture and Progress

Céline Benini, Secretary General Association of Manufacturers and Formulators of Enzyme Products

Marc Vermeulen, Sector Group Manager, Specialty Chemicals, The European Chemical Industry Council

Marie-Christine Ribera, Director General, European Association of Sugar Manufacturers

Jérôme Bandry, Secretary General, CEMA - European Agricultural Machinery Industry Association

Céline Duroc, Permanent Delegate CEPM, European Confederation of Maize Production

Elisabeth Lacoste, Director C.I.B.E.-International Confederation of European Beet Growers

Iliana Axiotiades, Secretary General, European Association of Cereals, Rice, Feedstuffs, Oil Seeds, Olive Oil, Oils and Fats and Agrosupply Trade

Diane Doré, Secretary General, Confederation of European Yeast Producers

Pekka Pesonen, Secretary General, Copa and Cogeca

Olivier de Matos, Director General, CropLife Europe

Catherine Entzminger, Director General, European Cacoa Association

Ana Granados Chapatte, Director, European Forum of Farm Animal Breeders

Jakub Rusek, Secretary General, European Food & Fermentation Cultures Association

Francesco Vacondio, President, European Flour Milling Association

Claire Skentelbery, Director General, EuropaBio – The European Association for Bioindustries

Berta Redondo Benito, Secretary General, European Potato Trade Association

Amrit Nanda, Executive Manager, European Technology Platform Plants for the Future

Garlich von Essen, Secretary General, Euroseeds

Nuria Moreno, Secretary General, European Vegetable Protein Association

Marco Baldoli, Secretary General, Federation of European Rice Millers

Nathalie Lecocq, Director General, FEDIOL - EU Vegetable Oil and Protein Meal Industry Association

Alexander Döring, Secretary General, European Feed Manufacturers' Federation

Joerg Seifert, Secretary General, FEFANA - EU Association of Specialty Feed Ingredients and their Mixtures

Dirk Jacobs, Director General, Science and R&D, FoodDrinkEurope

Huub Scheres, President, Primary Food Processors

Jamie Fortescue, Managing Director, Starch Europe

Policy Proposal for New Genomic Techniques - Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides


Download

22.0786 final joint Letter NGTs 14-11-2022Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
25/06/2025

Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.